BARCLAYS PLC - POINT BIOPHARMA GLOBAL INC ownership

POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 131 filers reported holding POINT BIOPHARMA GLOBAL INC in Q2 2023. The put-call ratio across all filers is 128.31 and the average weighting 0.2%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of POINT BIOPHARMA GLOBAL INC
ValueSharesWeighting
Q3 2023$949
-9.0%
142,257
+23.5%
0.00%0.0%
Q2 2023$1,043
+41.9%
115,227
+14.1%
0.00%
Q1 2023$735
-43.5%
100,958
-43.4%
0.00%
-100.0%
Q4 2022$1,301
-99.8%
178,498
+88.3%
0.00%0.0%
Q3 2022$733,000
+531.9%
94,803
+453.5%
0.00%
Q2 2022$116,000
+7.4%
17,129
+26.2%
0.00%
Q1 2022$108,00013,5780.00%
Other shareholders
POINT BIOPHARMA GLOBAL INC shareholders Q2 2023
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 2,312,523$18,431,0004.36%
GREAT POINT PARTNERS LLC 2,060,000$16,418,0003.97%
RA Capital Management 9,003,018$71,754,0001.57%
JOHNSON & JOHNSON 1,000,000$7,970,0001.51%
BVF INC/IL 3,367,826$26,842,0001.07%
Boxer Capital, LLC 2,500,000$19,925,0001.02%
Sio Capital Management, LLC 377,684$3,010,0001.00%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,014,408$24,025,0000.73%
SILVERARC CAPITAL MANAGEMENT, LLC 204,679$1,631,0000.68%
Atom Investors LP 60,103$479,0000.22%
View complete list of POINT BIOPHARMA GLOBAL INC shareholders